Reply  by Illuminati, Giulio & Ricco, Jean-Baptiste
LETTERS TO THE EDITOR
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pRegarding “Short-term results of a randomized trial
examining timing of carotid endarterectomy in
patients with severe asymptomatic unilateral carotid
stenosis undergoing coronary artery bypass grafting”
As a supporter of randomized trials in determining evidence-
based practice, I congratulate the authors on undertaking this
study, albeit within a cohort of patients who would previously have
been thought to be one of the lowest-risk subgroups for having
stroke after coronary artery bypass graft (CABG). Yet, despite
having excluded emergency procedures, non-CABG cardiac sur-
gery and those with significant aortic arch disease (52% of the
original cohort), patients with a unilateral asymptomatic 70% to
99% stenosis undergoing isolated CABG followed by delayed
carotid endarterectomy (CEA) incurred a 9% rate of death/stroke
at 90 days, compared with only 1% in those randomized to prior/
synchronous CEA.1
This is, of course, not the first time that a randomized trial has
contradicted the findings of systematic reviews of the available
literature, and it is likely that Illuminati’s study will be used to
justify prophylactic CEA (or carotid artery stenting) in this sub-
group of patients. So why (despite my enthusiasm for randomized
trials) do I harbor reservations? Notwithstanding the fact that this
constitutes high-level evidence, Illuminati’s results are so com-
pletely at variance with the published literature. First, no contem-
porary study has reported such a high number of post-CABG
strokes in patients with unilateral asymptomatic disease that were
also exclusively ipsilateral. Second, these data are also at variance
with large-scale, natural history studies which have shown that 90%
to 95% of post-CABG strokes were not attributable to carotid
disease.2-4 By contrast, Illuminati believes that 100% of their
strokes were carotid in origin. Third, any uncritical translation of
this trial’s findings into clinical practice (by others) would fail to
acknowledge the fact that the 1% 30-day risk of death/stroke in
patients undergoing prior/synchronous CEA was eight times
lower than meta-analyses of patients undergoing staged/synchro-
nous CEA or carotid artery stenting in the literature5,6 (a forum
where better, rather than worse, results tend to be published) and
also in a population based survey of 27,000 patients undergoing
synchronous CEA/CABG in the United States.7 It is hard to
believe that a 1% risk represents “real world” practice.
Accordingly, several issues do require clarification. First, there
was no mention of independent neurological evaluation (no neu-
rologists/physicians were listed as coauthors) and it is inevitable
that some observers will express surprise that 100% of such a large
number of strokes were exclusively ipsilateral. Did all patients
undergo independent neurological assessment and what was the
protocol for investigating procedural strokes? Did they all undergo
a magnetic resonance image/computed tomography to exclude
multiterritory/vertebrobasilar infarcts (ie, inconsistent with unilat-
eral carotid disease)? Second, there was no clarification about how
the late ipsilateral strokes were related to the delayed CEA. In the
text, we were told that all group B patients underwent delayed
CEA and that 4 patients had ipsilateral strokes on days 39, 50, 58,
and 66 post-CABG; but not whether any of these occurred within
30 days of the delayed CEA. This is essential information. In
conclusion, I retain no concerns about the choice of a 90-day end
point (others will corroborate whether days 30 to 90 are so
dangerous), but I do retain concerns about how this trial will
translate into clinical practice. Is it possible that virtually all of the
contemporary studies in the published literature were so com-
pletely wrong?
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We thank Dr Naylor for his comments.
The reason in this study for the high number of post-coronary
rtery bypass grafting (CABG) strokes ipsilateral to an asymptom-
tic carotid stenosis, compared with some contemporary studies
uoted by Dr Naylor, is probably twofold: first, in almost all of
hese studies, the follow-up was limited to 30 days after CABG,
nd second, a large number of patients had a moderate carotid
tenosis between 50% to 70%, very different from what was ob-
erved in our randomized trial.
The reader will notice that our stroke rate at 30 days was 2.5%,
omparable to that of most other reports, including one by Nay-
or.1 However, as observed in this study, myocardial revasculariza-
ion may have a lengthy postoperative course forcing to delay a
taged carotid endarterectomy (CEA) beyond the 30 postoperative
ays with an added risk of stroke.
Another key element to understand the differences between
ur study and those cited by Dr Naylor is the degree of carotid
tenosis. The concern that combined or successive CEA/CABG
ould lead to higher stroke rates than in the Asymptomatic Ca-
otid Atherosclerosis Study2 caused us to restrict CEA only to
atients with severe carotid stenosis (70%), the majority of them
eing 80% to 90% stenosis. This is very different from Naylor’s
ecent meta-analyses,3,4 where all carotid stenoses above 50% were
onsidered as significant. We certainly agree with Dr Naylor that a
arge proportion of post-CABG strokes are attributable to athero-
mbolism from the ascending aorta, but in our series, systematic
reoperative use of computed tomography (CT) and transesoph-
geal echocardiography (TEE) allowed us to eliminate these pa-
ients from randomization to focus strictly on the potential risk of
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Volume 55, Number 1 Letters to the Editor 309associated carotid disease. We also excluded patients undergoing
urgent CABG and other associated cardiac operations to select
stable patients with a lesser risk of chronic atrial fibrillation and
stroke.
As a result, the 1% death and stroke rate observed in our
patients undergoing CEA/CABG and in stable cardiac conditions
is simply the result of proper teamwork in a high-volume center
with CEA being performed by trained vascular surgeons. Opposite
to what is suggested by Dr Naylor, we did not miss any stroke. All
the patients underwent independent neurologic examination cou-
pled with cerebral CT scanning, obtained upon clinical appearance
of any neurologic event to confirm the hemispheric location of
stroke consistent with an ipsilateral carotid stenosis.
Finally, to answer Dr Naylor’s last question, all the patients in
group B, undergoing CEA after CABG had an uneventful postop-
erative course.
In conclusion, our study demonstrates that severe asymptom-
atic carotid stenosis is in itself an important cause of stroke after
CABG and is not a surrogate for severe atherosclerotic disease in
the aortic arch as suggested by Naylor and others.4,5 Our findings
are in agreement with the ACC/AHA (2004) Guideline Update
for Coronary Bypass Graft Surgery by Eagle et al6 who recom-
mended CEA for patients with high-grade carotid stenosis (70% or
more) to be performed before or coincident with CABG.
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